Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-09-03 Purchase |
2021-09-07 08:25 am |
EXAGEN INC. | XGN | Johnson Wendy S. Director |
1,000 | $14.02 | $14,020 | 1,000 (Direct) |
View |
| 2021-07-14 Sale |
2021-07-15 5:33 pm |
Reneo Pharmaceuticals Inc. | RPHM | Johnson Wendy S. Chief Development Officer |
111,736 | $8.5 | $949,756 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-09 Option Award |
2023-06-13 4:35 pm |
N/A 2033-06-08 |
EXAGEN INC. | XGN | Johnson Wendy S. Director |
9,000 | $0 | 9,000 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 08:34 am |
N/A 2032-06-15 |
EXAGEN INC. | XGN | Johnson Wendy S. Director |
9,000 | $0 | 9,000 (Direct) |
View |
| 2021-07-08 Exercise |
2021-07-09 6:52 pm |
2017-09-01 2028-04-04 |
Reneo Pharmaceuticals Inc. | RPHM | Johnson Wendy S. Chief Development Officer |
111,736 | $0 | 111,736 (Direct) |
View |
| 2021-07-08 Exercise |
2021-07-09 6:52 pm |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | Johnson Wendy S. Chief Development Officer |
111,736 | $1.97 | 111,736 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 08:38 am |
N/A 2031-06-16 |
EXAGEN INC. | XGN | Johnson Wendy S. Director |
9,000 | $0 | 9,000 (Direct) |
View |
Ownership |
2021-04-08 5:02 pm |
2017-09-01 2028-04-04 |
Reneo Pharmaceuticals Inc. | RPHM | Johnson Wendy S. Chief Development Officer |
0 | $0 | 257,440 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-01 4:33 pm |
N/A 2030-09-30 |
EXAGEN INC. | XGN | Johnson Wendy S. Director |
15,000 | $0 | 15,000 (Direct) |
View |